Hepatitis B prevalence during pregnancy.
Indian Pediatr
;
2009 Nov; 46(11): 1005-1008
Article
Dans Anglais
| IMSEAR
| ID: sea-144221
ABSTRACT
In order to determine the efficacy of a new hepatitis B immune globulin (HBIG), a phase 3, vertical transmission (mother to child) clinical interventional trial of hepatitis B virus (HBV) post exposure prophylaxis (PEP) was conducted at selected sites (n=15) throughout India. This required a large screening program for HBsAg positivity at prenatal clinics located in tertiary care hospitals. 36,379 pregnant women consented to be tested for Hepatitis B surface antigen (HBsAg) by Rapid Test and if positive-confirmed by ELISA. The weighted mean prevalence was 0.82% (95% CI, 0.72, 0.91). In conclusion, the prevalence of HBV carrier state during pregnancy in India in this study was low compared to previous reports.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Complications infectieuses de la grossesse
/
Prise en charge prénatale
/
Femelle
/
Humains
/
Grossesse
/
Prévalence
/
Hépatite B
/
Antigènes de surface du virus de l'hépatite B
/
Inde
Type d'étude:
Étude de prévalence
/
Facteurs de risque
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Indian Pediatr
Année:
2009
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS